[1] |
Dilinuer TAXIMAIMAITI, Palida ABULIZI.
Efficacy and safety of abrocitinib and dupilumab in the treatment of moderate to severe atopic dermatitis
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(8): 533-537.
|
[2] |
GUO Shuting, LI Ruijie, YANG Meili, JIN Yaqiao, ZHAO Yiyu, ZHANG Lu, HAN Hui, HAO Yong.
Effect of dupilumab on Staphylococcus aureus colonization in adults with moderate to severe atopic dermatitis
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(8): 545-549.
|
[3] |
TANG Xianyan, GENG Lingling, ZHAO Siyu, WEN Xinran, LI Xiaoqing.
Relationship between severe drug eruption and HLA genes caused by antiepileptic drugs
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(7): 461-465.
|
[4] |
TAO Rong, YANG Shuxia.
A retrospective study on factors related to female androgenetic alopecia
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(6): 402-405.
|
[5] |
XU Yuanyuan, GUO Linghong, WU Shuwei, ZHANG Ting, ZHANG Lu, JIANG Xian.
Causal associations between three atopic diseases and alopecia areata: a two-sample Mendelian randomization study
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(4): 239-244.
|
[6] |
CHEN Xueqin, SONG Zhiqiang.
Update of skin tissue-resident memory T cells and inflammatory skin diseases recurrence
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(4): 292-296.
|
[7] |
HAN Jinghong, LIU Hong.
Two children with refractory atopic dermatitis successfully treated with Janus kinase inhibitors
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(3): 190-192.
|
[8] |
LI Yanbo, ZHU Junrong, WANG Shangshang.
Bullous pemphigoid secondary to atopic dermatitis: a case report
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(11): 809-811.
|
[9] |
HUANG Gerile, ZHANG Wenjing, YANG Hongxin, GUO Hao.
Efficacy and safety of Janus kinase inhibitors for moderate-to-severe atopic dermatitis: a network meta-analysis
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(10): 690-698.
|
[10] |
ZHOU Xiaonan, CAO Chunyan, SHI Yaping, QI Maoxuan, ZHANG Qianying, ZONG Yan.
Latent profile analysis of family management characteristics in children with atopic dermatitis
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(1): 39-44.
|
[11] |
ZHANG Likun, YUE Wuheng, ZOU Zhengyun.
Update of chimeric antigen receptor T cell in malignant melanoma
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(1): 59-65.
|
[12] |
WEI Mingjing, CHEN Wenqi.
Update of TRPV3 in the occurrence and treatment of skin diseases
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(1): 66-70.
|
[13] |
YANG Xiaoli, DENG Danqi.
Research progress of atopic dermatitis and metabolic syndrome
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(8): 614-618.
|
[14] |
YANG Zijing, PAN Meng, ZHAO Xiaoqing.
Dupilumab-induced immune drifting from atopic dermatitis to polymyalgia rheumatica: a case report
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(7): 508-511.
|
[15] |
HONG Anlan, LIN Tong.
Update of the role for TRP channels in inflammatory skin diseases
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(2): 129-133.
|